Metabolic Explorer Stock

Metabolic Explorer Equity

Delisted

The The Equity of Metabolic Explorer (METEX.PA) as of Jul 31, 2026 is 103.69 M EUR. In the previous year, The Equity was 155.41 M EUR — a change of -33.28% (lower).

Equity

103.69 MEUR

YoY

-33.28%

Last updated:

In 2026, Metabolic Explorer's equity was 103.69 M EUR, a -33.28% increase from the 155.41 M EUR equity in the previous year.

Access this data via the Eulerpool API

Metabolic Explorer Stock analysis

What does Metabolic Explorer do? Metabolic Explorer SA is a French biotechnology company that was founded in 1999. It is headquartered in Clermont-Ferrand, France and employs approximately 70 employees, including scientists and engineers. The company specializes in the development and production of natural raw materials that are used in various industries such as cosmetics, food, and pharmaceuticals. The business model of Metabolic Explorer is based on innovative biological technology that enables the production of novel bio-based molecules by optimizing the metabolic processes of microorganisms. These novel molecules have higher quality and efficiency than conventional raw materials, making them promising alternatives for various industries. The company has specialized in various business areas. One of the most important is the production of bio-based amino acids used in the cosmetics and food industries. Metabolic Explorer has developed a patented method for producing amino acids from renewable resources such as plants and bacteria. This allows for amino acids to be produced without the use of petrochemical raw materials, making them more environmentally friendly and sustainable alternatives. Another business area of Metabolic Explorer is the production of bio-based lactic acid. Lactic acid is an important raw material for the production of bio-polymers, such as PLA (polylactic acid), used in the packaging industry. Again, Metabolic Explorer has developed a patented technology for producing lactic acid from renewable resources. Metabolic Explorer is also involved in the research and development of bio-molecules. The company works closely with various research institutions to optimize its biological technologies and processes and develop new applications. The goal is to improve the production of bio-based molecules and reduce costs. An example of Metabolic Explorer's innovative products is bio-based nylon precursor. Nylon is typically produced from petrochemical raw materials, leading to high costs and environmental impact. However, Metabolic Explorer has developed a patented technology that allows for the production of bio-based precursors that can be used as raw materials for nylon production. These bio-based precursors are made from renewable resources and can enable a more environmentally friendly and sustainable nylon. Metabolic Explorer has a variety of partnerships and collaborations with companies in various industries. One example is the collaboration with food company Roquette to develop bio-based glycerin products. Another partnership is with cosmetics company L'Oréal to develop bio-based lactic acid for use in cosmetics. Overall, Metabolic Explorer specializes in the development and production of bio-based molecules that offer a promising alternative to conventional petrochemical raw materials. With its patented biological technologies, the company is well-positioned to make a significant contribution to sustainability in various industries. Metabolic Explorer is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Metabolic Explorer's Equity

Metabolic Explorer's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Metabolic Explorer's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Metabolic Explorer's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Metabolic Explorer's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Metabolic Explorer’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Metabolic Explorer stock

The Equity of Metabolic Explorer is 103.69 M EUR in 2026.

Access this data via the Eulerpool API

Balance Sheet — Metabolic Explorer

All Key Metrics — Metabolic Explorer